Calidi Biotherapeutics appoints Alan R. Stewart as Class I director

Calidi Biotherapeutics, Inc.

Alan R. Stewart appointed Class I director effective October 10, 2023.
He also joined the Audit Committee and Compensation Committee.
Received options to purchase 52,500 shares at $3.32 per share.
Stewart is CFO of Soundthinking, Inc. with M&A and finance expertise.

item 5.02 item 9.01

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Appointed

Alan R. Stewart

Class I director

CLDI · Calidi Biotherapeutics, Inc.

Effective: 2023-10-10
Filed: October 24, 2023, 7:59 PM ET

On October 10, 2023, the Company announced the appointment of Mr. Alan R. Stewart as the Class I director of the Company, effective immediately

Key facts

Extracted from this filing and checked against the source text.

Executive change SEC 8-K Item 5.02 confidence 0.95

Alan R. Stewart was appointed as Class I director at Calidi Biotherapeutics, Inc..

Action: appointed
Role: Class I director

Exact text from the filing

On October 10, 2023, the Company announced the appointment of Mr. Alan R. Stewart as the Class I director of the Company, effective immediately

View on SEC.gov

Calidi Biotherapeutics, Inc. filing history →

Source: SEC EDGAR

accession 0001493152-23-038156

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.